WHO issued a report in late March on a meeting held in October to discuss “substandard/spurious/falsified/counterfeit medical products.” The report includes recommendations for health authorities on strategies for detecting and dealing with suspect and substandard medicines, as well as the prioritized actions member states are taking to prevent their production and distribution.
[/membership][membership level=”0,4″][The content continues for paid members only.]
Login or Subscribe [/membership][membership level=”1,5,6,7,8,9,10,11,12″][membership]
